Medical
The companies featured on PressReleaseFinder are active in several industries.
4 Jun 2014
First results confirm drug discovery potential of the European Lead Factory
Launched in January 2013, the Innovative Medicines Initiative (IMI)-funded* project gives the entire European research community access to a unique, high quality and extensive lead-like compound library, the Joint European Compound Library (JECL). The European Lead Factory also offers the cutting-edge infrastructure and expertise needed to screen against novel biological targets. This creates an outstanding opportunity to discover novel compounds, summarized in a so-called Qualified Hit List (QHL), for use either as pharmacological tools or as the starting points for drug discovery projects.
20 Mar 2014
Pediatric Praziquantel Consortium awarded US$1.86 million GHIT grant
Leiden, The Netherlands, March 20, 2014 - The Pediatric Praziquantel Consortium, launched in 2012 as an international non-profit public-private partnership, has announced that it has been awarded a prestigious research grant from the Japanese Global Health Innovative Technology (GHIT) Fund. The grant supports the Consortium's clinical development program of a newly developed praziquantel pediatric formulation targeted for use in very young children, including infants and toddlers, infected with schistosomiasis.
Muttenz, February 12, 2014 - Clariant, a world leader in specialty chemicals, represented by its business line Healthcare Packaging, will exhibit its expanding portfolio of protective packaging for pharmaceuticals at Pharmapack Europe 2014 Paris. A long time leader in pharmaceutical desiccants, oxygen scavengers and specialized container closure systems, Clariant Healthcare Packaging, along with Clariant Medical Masterbatches, will once again present its solutions to customers at PharmaPack. 
Muttenz, February 12, 2014 - Clariant, a world leader in specialty chemicals, through its Healthcare Packaging business segment, has announced a partnership and collaboration with PumpArt System® for the introduction of an innovative airless dispensing technology, Tubairless®, to the pharmaceutical industry.
Muttenz, February 12, 2014 – Clariant, one of the world leaders in specialty chemicals, In the Healthcare sector, coloration of plastics plays an important role in protecting patients by identifying drug types or doses, thereby reducing the risk of errors. However, these plastic packaging materials and the colorants in them need assessment of how they behave in contact with the drug during storage and use. These extractable and leachable studies on the packaging material, play an important role in medium and high risk applications such as ocular medicines, but if something changes in the polymers or masterbatches used to manufacture the packaging, then the data from the extractable and leachable studies may no longer be valid. To address these issues Clariant has used in dedicated expertise to create a new range of standard masterbatch colors, offering the benefits of the MEVOPUR® brand, tailored to the color standard developed by the American Society of Ophthalmology. 
Muttenz, February 12, 2014 – Clariant, one of the world leaders in specialty chemicals, supports the Healthcare industry with a range of products developed for medical devices and pharmaceutical plastic packaging. With its knowledge, Clariant’s MEVOPUR® nucleant product brings improvements in the process of plastic packaging fabrication. Thanks to them the processing time can be reduced; mechanical properties improved and so companies can save time and increase the productivity. The nucleating agents used in MEVOPUR products are pre-tested using extraction protocols such as those established by US Pharmacopeia, ISO and NEW European Pharmacopeia monograph 3.1.3; the goal is helping companies to meet the challenging regulatory requirements to support “Controlled, Consistent and Compliant”.